HIV envelope protein inhibits MHC class I presentation of a cytomegalovirus protective epitope

Journal of Immunology

Volumn 167, Issue 8, 2001, Pages 4238-4244

  Lopez D ^a   Samino, Y ^a   Koszinowski, U H ^a   Del Val, M ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; ENVELOPE PROTEIN; EPITOPE; GLYCOPROTEIN GP 120; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHOSPHOPROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; COMPETITIVE INHIBITION; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; IMMUNOCOMPETENCE; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROCESSING; STRAIN DIFFERENCE;

EID: 0035887753     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.8.4238     Document Type: Article

References (48)

1. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells
2. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
3. Antigenic oscillations and shifting immunodominance in HIV-1 infections
4. Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin
5. Selective involvement of proteasomes and cysteine proteases in MHC class I Ag presentation
6. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I Ag presentation
7. Genreodin of MHC class I peptide antigens by protein processing in the secretory route by furin
8. Cytotoxic T cell repertoire selection: A single amino acid determines alternative class I restriction
9. Molecular basis of cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89
10. A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160
11. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules
12. Epitope recognition of conserved HIV envelope sequences by human cytotoxic T lymphocytes
13. Cytotoxic T lymphocytes specific for HIV-1 gp160 antigen and synthetic P18IIIB peptide in an HLA-AII-immunized individual
14. Envelope protein and p18(IIIB) peptide recognized by cytotoxic T lymphocytes from humans immunized with human immunodeficiency virus envelope
15. Identification of self peptides bound to purified HLA-B27
16. Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase
17. Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope
18. A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection
19. d serologic recognition
20. Peptides control the gain and loss of allele specificity by mutated MHC class I molecules
21. Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the Ag-processing mutant 174XCEM.T2
22. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein
23. Expression of the HTLV-III envelope gene by a recombinant vaccinia virus
24. d Ag, the products of a third polymorphic locus of the mouse MHC
25. Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function
26. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells
27. + T cells
28. + CTL
29. Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses
30. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160
31. - cells
32. An O-linked carbohydrate neutralization epitope of HIV-1 gpl20 is expressed by HIV-1 ENV gene recombinant vaccinia virus
33. Multiple pathways are involved in the extracellular processing of MHC class-l-restricted peptides
34. d epitope is generated and translocated into the endoplasmic reticulum as an 11-mer precursor peptide
35. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment
36. Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules
37. Peptide selection by MHC-encoded TAP transporters
38. Different MHC class I alleles compete for presentation of overlapping viral epitopes
39. Immunodominance does not result from peptide competition for MHC class II presentation
40. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes
41. Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes
42. MHC affinity, peptide liberation. T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL
43. HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor
44. Cytomegalovirus as a possible cofactor in HIV disease progression
45. HIV and HCMV coinfect brain cells in patients with AIDS
46. Cytomeg-alovirus as a primary pulmonary pathogen in AIDS
47. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4
48. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120